GO:0016918 retinal binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016918 retinal binding is a molecular function describing the binding of retinal, a vitamin A derivative, to proteins such as opsins and retinoid-binding proteins [1,3,6].
• Retinal binding is essential for vision, as retinal combines with opsins to form visual pigments in the retina.
• All-trans-retinal binding can lead to photodamage and ferroptosis in photoreceptors and retinal pigment epithelium [2,4,5].
• Interphotoreceptor retinoid-binding protein (IRBP) removes all-trans-retinol and retinal from rod outer segments, preventing lipofuscin precursor formation.
• Some rhodopsins, such as peropsin, bind all-trans-retinal and may act as dark-active, light-inactivated GPCRs.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable functional dissection of retinal-binding proteins in health and disease [1,2,5].
Description
Retinal binding (GO:0016918) is a molecular function defined as the binding to retinal, one of the forms of vitamin A. Retinal plays an important role in the visual process in most vertebrates, combining with opsins to form visual pigments in the retina. This function is central to phototransduction and is mediated by a diverse set of proteins, including visual pigments such as rhodopsin and cone opsins, as well as retinoid-binding proteins like interphotoreceptor retinoid-binding protein (IRBP) [6,7]. The binding of retinal to these proteins is not merely a static interaction; it involves specific structural determinants that control isomerization, activation, and downstream signaling [1,8]. Research on retinal binding has broad implications beyond vision. All-trans-retinal, a key intermediate in the visual cycle, can accumulate under certain conditions and trigger photodamage, ferroptosis, and degeneration of photoreceptors and retinal pigment epithelium [2,4,5]. Understanding how proteins bind retinal and how this binding is regulated is therefore critical for developing therapeutic strategies against retinal degenerative diseases. Moreover, the structural basis of retinal binding has been illuminated by studies on microbial rhodopsins and flotillin-associated rhodopsins, revealing both canonical and non-canonical binding modes [1,8]. These findings underscore the evolutionary conservation and diversity of retinal-binding proteins. For researchers, GO:0016918 provides a precise annotation for genes and proteins that interact with retinal. It enables functional enrichment analysis, target identification, and mechanistic studies. The availability of CRISPR tools now allows systematic interrogation of retinal-binding proteins in cellular and animal models, accelerating the translation of basic findings into clinical applications [1,2,5].
retinal binding At A Glance
| GO ID | GO:0016918 |
|---|---|
| GO term | retinal binding |
| Ontology | molecular_function |
| Synonym | blue-sensitive opsin, green-sensitive opsin, long-wave-sensitive opsin, opsin, red-sensitive opsin, retinaldehyde binding, short-wave-sensitive opsin, UV-sensitive opsin, violet-sensitive opsin, vitamin A binding |
| Major function | Binding to retinal, a vitamin A derivative, to form visual pigments and mediate phototransduction |
| Definition | Binding to retinal, one of the forms of vitamin A. Retinal plays an important role in the visual process in most vertebrates, combining with opsins to form visual pigments in the retina. |
| Related proteins | Rhodopsin, cone opsins, peropsin, halorhodopsin, interphotoreceptor retinoid-binding protein (IRBP) |
| Disease relevance | Retinal degeneration, photodamage, ferroptosis, lipofuscin accumulation |
| Research methods | CRISPR knockout/knock-in, structural biology, spectroscopy, ferroptosis assays |
What Is GO:0016918?
GO:0016918 retinal binding is a molecular function term that describes the selective interaction of a protein or biomolecule with retinal, a form of vitamin A. Retinal is a chromophore that covalently or non-covalently binds to opsins to form visual pigments, which are essential for light detection in the retina. The term encompasses binding to all-trans-retinal, 11-cis-retinal, and other retinal isomers, as well as retinaldehyde. Proteins annotated with this function include visual pigments (rhodopsin, cone opsins), peropsin, halorhodopsin, and retinoid-binding proteins such as IRBP [3,6,7,8].
Why Is retinal binding Important in Cell Biology?
Retinal binding is fundamental to vision and to the maintenance of retinal health. Proteins that bind retinal, such as rhodopsin and cone opsins, initiate the phototransduction cascade that converts light into electrical signals. Disruption of retinal binding or accumulation of free all-trans-retinal can lead to photoreceptor cell death, ferroptosis, and retinal degenerative diseases [2,4,5]. Furthermore, retinal-binding proteins like IRBP are critical for retinoid transport and recycling, preventing toxic byproduct formation. Thus, understanding retinal binding at molecular, cellular, and organismal levels is essential for both basic vision science and therapeutic development.
• Retinal binding is required for the formation of visual pigments and phototransduction in rods and cones.
• All-trans-retinal accumulation causes photodamage and ferroptosis in photoreceptors and retinal pigment epithelium [2,4,5].
• IRBP removes all-trans-retinol and retinal from rod outer segments, preventing lipofuscin precursor formation.
• Peropsin binds all-trans-retinal and may function as a dark-active, light-inactivated GPCR.
• Structural studies of halorhodopsin reveal mechanisms of retinal binding and thermal isomerization.
• Flotillin-associated rhodopsins can lack retinal binding, highlighting diversity in retinal-binding proteins.
• Retinal binding is implicated in retinal degenerative diseases such as age-related macular degeneration and retinitis pigmentosa [2,5].
• CRISPR-based models enable functional validation of retinal-binding proteins in disease contexts [1,2,5].
• Retinal binding is a target for therapeutic interventions using ferroptosis inhibitors.
• GO:0016918 annotations facilitate gene enrichment and network analyses in vision research [1,3,6].
Molecular Mechanism of retinal binding
Retinal binding to opsins
In simple terms: Retinal attaches to opsin proteins to form light-sensitive pigments.
Opsins, such as rhodopsin and cone opsins, bind 11-cis-retinal covalently via a Schiff base linkage to a conserved lysine residue. This binding forms the visual pigment that absorbs light and triggers phototransduction. The binding pocket is formed by seven transmembrane helices, and specific amino acids determine the spectral tuning of different opsins [1,6].
All-trans-retinal binding and release
In simple terms: After light activation, retinal changes shape and is released from the opsin.
Light isomerizes 11-cis-retinal to all-trans-retinal, which then dissociates from the opsin. All-trans-retinal can bind to other proteins, such as peropsin, which may act as a dark-active, light-inactivated GPCR. The release and rebinding of retinal are critical for the visual cycle and for preventing toxic accumulation [4,7].
Retinoid transport and binding proteins
In simple terms: Special proteins carry retinal and related molecules between cells to protect the retina.
Interphotoreceptor retinoid-binding protein (IRBP) binds all-trans-retinol and retinal in the interphotoreceptor matrix, facilitating their removal from rod outer segments and preventing lipofuscin precursor formation. This transport function is essential for retinal health and for the recycling of retinoids.
Structural determinants of retinal binding
In simple terms: The shape of the protein pocket determines whether and how retinal binds.
Structural studies of halorhodopsin from Natronomonas pharaonis have revealed key residues that control retinal binding and thermal isomerization. In flotillin-associated rhodopsins, the absence of retinal binding is due to specific structural features, demonstrating that not all rhodopsins bind retinal. These findings highlight the importance of protein architecture in retinal binding.
Retinal binding and ferroptosis
In simple terms: When retinal builds up, it can cause a type of cell death called ferroptosis.
All-trans-retinal can activate GSDME, increasing sensitivity to photoreceptor ferroptosis. Ferroptosis inhibitors such as ferrostatin-1 mitigate all-trans-retinal-induced retinal pigment epithelium degeneration in mice. Thus, retinal binding and its dysregulation are directly linked to cell death pathways.
Key Genes Involved in GO:0016918 retinal binding
The following genes and proteins are key players in retinal binding, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RHO | Binds 11-cis-retinal to form rhodopsin, the visual pigment in rods | Mutations cause retinitis pigmentosa; model for retinal binding studies |
| OPN1SW | Binds retinal to form blue-sensitive opsin | Cone photoreceptor function; spectral tuning |
| OPN1MW | Binds retinal to form green-sensitive opsin | Cone photoreceptor function; color vision |
| OPN1LW | Binds retinal to form red-sensitive opsin | Cone photoreceptor function; color vision |
| RRH | Peropsin, binds all-trans-retinal; potential dark-active GPCR | Retinal pigment epithelium function; light response |
| RGR | Retinal G protein-coupled receptor, binds all-trans-retinal | Retinoid metabolism and visual cycle |
| RLBP1 | Cellular retinaldehyde-binding protein, binds retinal | Retinoid transport; mutations cause retinal dystrophy |
| RBP3 | Interphotoreceptor retinoid-binding protein (IRBP), binds retinal | Prevents lipofuscin formation; retinal health |
| GSDME | Activated by all-trans-retinal, mediates ferroptosis | Photoreceptor cell death; therapeutic target |
| Halo | Halorhodopsin, binds retinal for light-driven chloride transport | Model for retinal binding and isomerization |
| Flotillin-associated rhodopsin | Lacks retinal binding; structural insights | Evolution of retinal-binding proteins |
| ABCA4 | Transports all-trans-retinal; mutations cause Stargardt disease | Retinal degeneration; lipofuscin accumulation [4,7] |
| RPE65 | Isomerohydrolase in visual cycle; produces 11-cis-retinal | Retinal binding and regeneration |
| LRAT | Lecithin retinol acyltransferase; esterifies retinol | Retinoid metabolism; visual cycle |
| CRALBP | Cellular retinaldehyde-binding protein; binds 11-cis-retinal | Retinoid transport in Müller cells |
| SLC24A1 | Sodium/calcium-potassium exchanger; not directly retinal binding | Photoreceptor function; indirect role |
| GNAT1 | Transducin alpha subunit; interacts with rhodopsin | Phototransduction downstream of retinal binding |
How Is retinal binding Regulated?
Retinal binding is regulated at multiple levels. The availability of retinal isomers is controlled by enzymes of the visual cycle, such as RPE65 and LRAT [4,7]. The binding affinity of opsins for retinal can be modulated by post-translational modifications and by interactions with other proteins, such as arrestin and transducin. Additionally, the removal of all-trans-retinal by IRBP and ABCA4 prevents toxic accumulation and regulates the pool of free retinal. Ferroptosis pathways, including GSDME activation, are also regulated in response to retinal binding and accumulation [2,5].
retinal binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCA4 | Stargardt disease, lipofuscin accumulation | ABCA4 knockout mice, iPSC-derived RPE [4,7] |
| RHO | Retinitis pigmentosa | RHO point-mutation knock-in mice |
| GSDME | Ferroptosis in photoreceptors | GSDME knockout mice, ferroptosis assays |
| RBP3 | Retinal degeneration, lipofuscin formation | RBP3 knockout mice |
| RPE65 | Leber congenital amaurosis | RPE65 knockout mice, gene therapy models |
Retinal degeneration and photodamage
Excessive all-trans-retinal binding and accumulation can cause photodamage and degeneration of photoreceptors and retinal pigment epithelium. This process involves ferroptosis, as all-trans-retinal activates GSDME and increases sensitivity to ferroptotic cell death. Ferroptosis inhibitors such as ferrostatin-1 mitigate all-trans-retinal-induced RPE degeneration in mice, suggesting therapeutic potential. Mutations in ABCA4, which transports all-trans-retinal, lead to Stargardt disease and lipofuscin accumulation [4,7].
Retinitis pigmentosa and cone dystrophies
Mutations in rhodopsin (RHO) and cone opsins can impair retinal binding, leading to retinitis pigmentosa and cone dystrophies. Defective retinal binding disrupts phototransduction and causes progressive photoreceptor loss. Structural studies of rhodopsin mutants provide insights into the molecular basis of these diseases [1,6].
Ferroptosis in retinal diseases
All-trans-retinal-induced ferroptosis is emerging as a key mechanism in retinal degenerative diseases. GSDME activation by all-trans-retinal increases photoreceptor ferroptosis, and inhibition of ferroptosis protects against retinal degeneration [2,5]. This pathway links retinal binding to cell death and offers new targets for intervention.
From retinal binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X bind retinal? | In vitro retinal binding assay with purified protein |
| What is the effect of a point mutation on retinal binding? | CRISPR point-mutation knock-in cell line [1,6] |
| How does loss of gene X affect retinal degeneration? | CRISPR knockout mouse or iPSC-derived photoreceptors [2,5] |
| Can overexpression of gene X protect against ferroptosis? | Overexpression cell model with ferroptosis induction [2,5] |
| Where is gene X expressed in the retina? | Tagged knock-in reporter mouse |
| Does gene X interact with retinal in live cells? | FRET-based retinal sensor or imaging [3,8] |
How to Study the retinal binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| UV-Vis spectroscopy | Absorbance of retinal-opsin complex | Retinal binding and isomerization [6,8] |
| X-ray crystallography | Atomic structure of retinal-binding pocket | Structural determinants of binding |
| Cryo-EM | Structure of large retinal-binding complexes | Flotillin-associated rhodopsins |
| CRISPR knockout screen | Genes required for retinal binding or toxicity | Ferroptosis modifiers [2,5] |
| Lipid peroxidation assay | Ferroptosis induction | All-trans-retinal toxicity [2,5] |
| Immunofluorescence | Localization of retinal-binding proteins | Retina tissue sections |
| FRET | Real-time retinal binding in live cells | Dynamic binding studies |
| Mass spectrometry | Retinoid quantification | Visual cycle metabolites |
Structural biology (X-ray crystallography, cryo-EM)
Structural methods reveal the atomic details of retinal binding pockets and conformational changes. For example, crystal structures of halorhodopsin show retinal and key residues involved in binding and isomerization. Cryo-EM can capture large complexes and dynamic states.
Spectroscopy (UV-Vis, fluorescence)
UV-Vis spectroscopy is used to monitor retinal binding and isomerization by measuring absorbance shifts. Fluorescence spectroscopy can detect conformational changes upon retinal binding [6,8].
CRISPR-based genetic screens
Genome-wide CRISPR screens can identify genes required for retinal binding, transport, or toxicity. Knockout libraries enable unbiased discovery of modifiers of all-trans-retinal-induced ferroptosis [2,5].
Ferroptosis and cell death assays
Lipid peroxidation, GSDME activation, and cell viability assays measure the functional consequences of retinal binding and accumulation. Ferrostatin-1 is used to rescue ferroptosis [2,5].
How CRISPR Can Be Used to Study GO:0016918 retinal binding
Knockout
CRISPR knockout of retinal-binding genes (e.g., RHO, RBP3, ABCA4) in cell lines or mice abolishes retinal binding and reveals downstream effects on phototransduction, retinoid transport, and cell survival [2,5,7]. Knockout models are essential for validating gene function in retinal degeneration.
Point Mutation
Point mutations in retinal-binding proteins can alter binding affinity or specificity. CRISPR-mediated point mutation knock-in models (e.g., RHO mutations) mimic human disease alleles and allow precise structure-function studies [1,6].
Knock-in
Knock-in of tagged or reporter versions of retinal-binding proteins enables visualization and biochemical isolation. For example, fluorescent tags on opsins allow live-cell imaging of retinal binding dynamics [3,7].
Overexpression
Overexpression of retinal-binding proteins or protective factors can rescue phenotypes or exacerbate toxicity. Overexpressing ferroptosis inhibitors or retinal-binding proteins in cell models helps dissect protective mechanisms [2,5].
How EDITGENE Supports retinal binding Research
Researchers studying retinal binding-related genes often need to determine whether a candidate gene is causally involved in retinal function, degeneration, or ferroptosis. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell and animal models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for retinal binding research.
Frequently Asked Questions About retinal binding
What is retinal binding?
Retinal binding is a molecular function (GO:0016918) where a protein binds retinal, a form of vitamin A, to form visual pigments or transport retinoids [1,6].
What genes are involved in retinal binding?
Key genes include RHO, OPN1SW, OPN1MW, OPN1LW, RRH, RGR, RLBP1, RBP3, ABCA4, and RPE65 [3,6,7].
How does retinal binding relate to vision?
Retinal binding to opsins forms visual pigments that absorb light and initiate phototransduction, the first step in vision.
What diseases are associated with defective retinal binding?
Defective retinal binding is linked to retinitis pigmentosa, Stargardt disease, cone dystrophies, and ferroptosis-mediated retinal degeneration [2,4,5].
What is all-trans-retinal and why is it important?
All-trans-retinal is a retinal isomer that can accumulate and cause photodamage and ferroptosis in the retina [2,4,5].
How can CRISPR be used to study retinal binding?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of retinal-binding proteins in cells and animals [1,2,5].
What is the role of IRBP in retinal binding?
Interphotoreceptor retinoid-binding protein (IRBP) binds all-trans-retinol and retinal, removing them from rod outer segments and preventing lipofuscin formation.
What is peropsin and how does it bind retinal?
Peropsin (RRH) binds all-trans-retinal and may act as a dark-active, light-inactivated GPCR in the retinal pigment epithelium.
What methods are used to study retinal binding?
Methods include UV-Vis spectroscopy, X-ray crystallography, cryo-EM, CRISPR screens, and ferroptosis assays [2,6,8].
How does retinal binding lead to ferroptosis?
All-trans-retinal activates GSDME, increasing sensitivity to photoreceptor ferroptosis; ferroptosis inhibitors can mitigate this effect [2,5].
Conclusion
GO:0016918 retinal binding is a fundamental molecular function that underpins vision and retinal health. Its dysregulation leads to photodamage, ferroptosis, and degenerative diseases. Advances in structural biology and CRISPR-based models are illuminating the mechanisms and therapeutic opportunities. EDITGENE provides comprehensive CRISPR services to accelerate research on retinal-binding proteins and their roles in disease.
References
- 1. Kovalev K et al.. 2025. Structural basis for no retinal binding in flotillin-associated rhodopsins.. Structure 33(9):1462-1469.e3 PMID: 40651474
- 2. Yang B et al.. 2025. Activation of GSDME by all-trans-retinal increases sensitivity to photoreceptor ferroptosis.. Int J Biol Sci 21(15):7029-7042 PMID: 41281747
- 3. Nagata T et al.. 2018. An all-trans-retinal-binding opsin peropsin as a potential dark-active and light-inactivated G protein-coupled receptor.. Sci Rep 8(1):3535 PMID: 29476064
- 4. Maeda T et al.. 2012. Retinal photodamage mediated by all-trans-retinal.. Photochem Photobiol 88(6):1309-19 PMID: 22428905
- 5. Shen X et al.. 2025. Ferrostatin-1, a ferroptosis inhibitor, mitigates all-trans-retinal-induced retinal pigment epithelium degeneration in mice.. J Transl Med 23(1):1103 PMID: 41094540
- 6. Tsukamoto H et al.. 2005. A rhodopsin exhibiting binding ability to agonist all-trans-retinal.. Proc Natl Acad Sci U S A 102(18):6303-8 PMID: 15851682
- 7. Chen C et al.. 2017. Interphotoreceptor retinoid-binding protein removes all-trans-retinol and retinal from rod outer segments, preventing lipofuscin precursor formation.. J Biol Chem 292(47):19356-19365 PMID: 28972139
- 8. Maiti TK et al.. 2009. Retinal-protein interactions in halorhodopsin from Natronomonas pharaonis: binding and retinal thermal isomerization catalysis.. J Mol Biol 394(3):472-84 PMID: 19766652
